SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,766.79+0.40%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Obsidian Therapeutics Inc (OBX) Stock Price, Quote, News & History

OBXNASDAQ
Trade with Public
Trade with Public
$12.86
-0.55-4.1%
At close: Sep 25, 5:00 PM EST
$12.86
N/A
After Hours: Sep 25, 4:35 PM EST
OverviewNewsPrice TargetsFinancialsSentimentCompareStock Report

Obsidian Therapeutics (OBX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$13.54
Close
$12.86
Volume / Avg.
454.56K / 418.30K
Day Range
$12.16 - $13.70
52 Wk Range
13.20 - 49.97
Market Cap
$794.40M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
26
Short Interest
-
Days to Cover
1

Recent Obsidian Therapeutics, Inc News

Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday

U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris, IonQ and quantum stocks also posted strong gains.
Avi Kapoor

Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday

US stocks down, Nasdaq falls 300+ points. Duos Tech shares rise on better Q2 results. Many other big stocks gain, including Duolingo, Intuit, and Newsmax.
Avi Kapoor

This Civeo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Analysts change outlook on top Wall Street names, including initiations, upgrades, and downgrades. Check our analyst ratings page for details.
Avi Kapoor

PRO
Leerink Partners Initiates Coverage On Obsidian Therapeutics with Outperform Rating, Announces Price Target of $32

Leerink Partners initiates coverage on Obsidian Therapeutics (NASDAQ:OBX) with a Outperform rating and announces Price Target of $32.
Benzinga Newsdesk

PRO
Obsidian Therapeutics Files Prospectus Related To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders

-SEC Filing
Benzinga Newsdesk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-88.04M
Investing Cash Flow (TTM)
75.52M
Financing Cash Flow (TTM)
61.00K
Free Cash Flow (TTM)
-88.06M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-12.46M

Analyst Trends and Forecast

2
Aug
2
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.6
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$742.95M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-11.51%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$4.47

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$26.44M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$13.54
Close
$12.86
Volume / Avg.
454.56K / 418.30K
Day Range
$12.16 - $13.70
52 Wk Range
13.20 - 49.97
Market Cap
$794.40M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
26
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The comp...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Obsidian Therapeutics (OBX) stock?

A

You can purchase shares of Obsidian Therapeutics (NASDAQ:OBX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Obsidian Therapeutics (OBX) competitors?

Q

What is the forecast, or price target, for Obsidian Therapeutics (OBX) stock?

A

Obsidian Therapeutics has a consensus price target of $39.00.

Q

What is the current price for Obsidian Therapeutics (OBX)?

A

The stock price for Obsidian Therapeutics (NASDAQ: OBX) is $12.86 last updated September 25, 2026 at 4:35 PM EDT.

Q

Does Obsidian Therapeutics (OBX) pay a dividend?

A

There are no upcoming dividends for Obsidian Therapeutics.

Q

When is Obsidian Therapeutics (NASDAQ:OBX) reporting earnings?

A

Obsidian Therapeutics does not have any upcoming earnings scheduled.

Q

Is Obsidian Therapeutics (OBX) going to split?

A

There is no upcoming split for Obsidian Therapeutics.

Q

What sector and industry does Obsidian Therapeutics (OBX) operate in?

A

Obsidian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved